Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Rationale: Consideration of lung transplantation in patients with systemic sclerosis (SSc) remains guarded, often due to the concern for esophageal dysfunction and the associated potential for allograft injury and suboptimal post–lung transplantation outcomes. Objectives: The purpose of this study was to systematically report our single-center experience regarding lung transplantation in the setting of SSc, with a particular focus on esophageal dysfunction. Methods: We retrospectively reviewed all lung transplants at our center from January 1, 2000 through August 31, 2012 (n = 562), comparing the SSc group (n = 35) to the following lung transplant diagnostic subsets: all non-SSc (n = 527), non-SSc diffuse fibrotic lung disease (n = 264), and a non-SSc matched group (n = 109). We evaluated post–lung transplant outcomes, including survival, primary graft dysfunction, acute rejection, bronchiolitis obliterans syndrome, and microbiology of respiratory isolates. In addition, we defined severe esophageal dysfunction using esophageal manometry and esophageal morphometry criteria on the basis of chest computed tomography images. For patients with SSc referred for lung transplant but subsequently denied (n = 36), we queried the reason(s) for denial with respect to the concern for esophageal dysfunction. Measurements and Main Results: The 1-, 3-, and 5-year post–lung transplant survival for SSc was 94, 77, and 70%, respectively, and similar to the other groups. The remaining post–lung transplant outcomes evaluated were also similar between SSc and the other groups. Approximately 60% of the SSc group had severe esophageal dysfunction. Pre–lung transplant chest computed tomography imaging demonstrated significantly abnormal esophageal morphometry for SSc when compared with the matched group. Importantly, esophageal dysfunction was the sole reason for lung transplant denial in a single case. Conclusions: Relative to other lung transplant indications, our SSc group experienced comparable survival, primary graft dysfunction, acute rejection, bronchiolitis obliterans syndrome, and microbiology of respiratory isolates, despite the high prevalence of severe esophageal dysfunction. Esophageal dysfunction rarely precluded active listing for lung transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“studies of scleroderma recipients, undergoing lung transplant at centers with expertise with this patient population, have demonstrated that esophageal dysfunction does not appear to impact outcomes.(36, 37)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-95 · Cited by 3,950
Stewart, S., Fishbein, M. C., Snell, G. I., Berry, G. J., Boehler, A., Burke, M. M., Glanville, A., Gould, F. K., Magro, C., Marboe, C. C., et al. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.10.017 · Cited by 2,442
The Chicago Classification of esophageal motility disorders, v3.0
Kahrilas, P. J., Bredenoord, A. J., Fox, M., Gyawali, C. P., Roman, S., Smout, A. J. P. M., Pandolfino, J. E., & International High Resolution Manometry Working Group (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12477 · Cited by 1,964
Aspiration Pneumonitis and Aspiration Pneumonia
Marik, P. E. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440908 · Cited by 1,627
Changes in causes of death in systemic sclerosis, 1972–2002
Steen, V. D., & Medsger, T. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066068 · Cited by 1,528
Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria
Estenne, M., Maurer, J. R., Boehler, A., Egan, J. J., Frost, A., Hertz, M., Mallory, G. B., Snell, G. I., & Yousem, S. (2002) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)00398-4 · Cited by 1,274
Christie, J. D., Carby, M., Bag, R., Corris, P., Hertz, M., & Weill, D. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.11.049 · Cited by 762
Clinical risk factors for primary graft dysfunction after lung transplantation
Diamond, J. M., Lee, J. C., Kawut, S. M., Shah, R. J., Localio, A. R., Bellamy, S. L., Lederer, D. J., Cantu, E., Kohl, B. A., Lama, V. N., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201210-1865oc · Cited by 687
Yusen, R. D., Christie, J. D., Edwards, L. B., Kucheryavaya, A. Y., Benden, C., Dipchand, A. I., Dobbels, F., Kirk, R., Lund, L. H., Rahmel, A. O., et al. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.08.007 · Cited by 506
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
“36,37 Hematologic abnormalities : Thrombocytopenia, leukopenia, or anemia may contribute to peri-operative complications and may limit use of optimal maintenance immunosuppression and necessary antimicrobial prophylaxis following lung transplant.”
BackgroundJeganathan, N., & Sathananthan, M. (2020) · Lung · doi:10.1007/s00408-020-00383-w · Cited by 143
Pradère, P., Tudorache, I., Magnusson, J. M., Savale, L., Brugière, O., Douvry, B., Reynaud‐Gaubert, M., Claustre, J., Borgne, A. L., Holm, A. M., et al. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.03.003 · Cited by 101
Lung transplantation for interstitial lung disease
Kapnadak, S. G., & Raghu, G. (2021) · European Respiratory Review · doi:10.1183/16000617.0017-2021 · Cited by 91
Major lung complications of systemic sclerosis
Denton, C. P., Wells, A. U., & Coghlan, G. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0062-0 · Cited by 91
Metadata
- Authors
- Miele, C. H., Schwab, K., Saggar, R., Duffy, E., Elashoff, D., Tseng, C.-H., Weigt, S., Charan, D., Abtin, F., Johannes, J., Derhovanessian, A., Conklin, J., Ghassemi, K., Khanna, D., Siddiqui, O., Ardehali, A., Hunter, C., Kwon, M., Biniwale, R., Lo, M., Volkmann, E., Torres Barba, D., Belperio, J. A., Sayah, D., Mahrer, T., Furst, D. E., Kafaja, S., Clements, P., Shino, M., Gregson, A., Kubak, B., Lynch, J. P., Ross, D., & Saggar, R.
- Affiliations
- University of California, Los Angeles (US)
- Michigan Medicine (US)
- University of Maryland, Baltimore (US)
- Lung and Heart-Lung Transplant and Pulmonary Hypertension Programs
- Department of Internal Medicine, David Geffen School of Medicine at the University of California Los Angeles
- Department of Pulmonary and Critical Care Medicine
- Kaiser Permanente (US)
- Corresponding author
- Saggar, Rajan
- ORCID
- Venue
- Annals of the American Thoracic Society
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-06-01
- Volume
- 13
- Issue
- 6
- Pages
- 793-802
- ISSN
- 2325-6621 (ISSN-L)
- 2329-6933
- PMC
- PMC5461989
- OpenAlex
- W2335976060
- Semantic Scholar
- 5d7bd7486b76621abd23996901b8bdf6e392ec29
- Cited by
- 81
- References
- 28
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 2 · 2021: 15 · 2020: 10 · 2019: 9 · 2018: 11 · 2017: 9 · 2016: 2
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of the American Thoracic Society (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23HL102220)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- lung transplantation, systemic sclerosis, esophageal dysfunction, post-transplant survival, primary graft dysfunction, acute rejection, bronchiolitis obliterans syndrome, respiratory infections, esophageal manometry, transplant listing
- MeSH terms
- Aged, Bronchiolitis Obliterans, Esophageal Diseases, Esophagus, Female, Graft Survival, Humans, Male, Middle Aged, Postoperative Complications, Retrospective Studies, Scleroderma, Systemic, Time Factors, United States, Multivariate Analysis, Survival Analysis, Lung Transplantation, Primary Graft Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience. https://app.cochat.ai/papers/10.1513/annalsats.201512-806oc
- The paper
- Miele, C. H., Schwab, K., Saggar, R., Duffy, E., Elashoff, D., Tseng, C.-H., Weigt, S., Charan, D., Abtin, F., Johannes, J., Derhovanessian, A., Conklin, J., Ghassemi, K., Khanna, D., Siddiqui, O., Ardehali, A., Hunter, C., Kwon, M., Biniwale, R., . . . Saggar, R. (2016). Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience. Annals of the American Thoracic Society. https://doi.org/10.1513/annalsats.201512-806oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.